Contacts: City of Hope Letisia Marquez lemarquez@coh.org 626-476-7593   Known as the City of Hope patient, he is the fourth patient in the world and the oldest to go...

National Hospital Week is an opportunity to highlight hospitals, health systems and health care workers and the innovative ways they are supporting and connected to patients and the community. As...

“People thought City of Hope was a ship!”   It’s hard to believe, but there was a time when the sprawling, globally recognized City of Hope we all recognize today...

CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   Chimeric antigen receptor (CAR)-NK cell therapy to treat the virus is one of more than two dozen COVID-19 research projects underway   DUARTE, Calif...

CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   DUARTE, Calif. — ProBioGen AG has announced a commercial product license agreement with City of Hope®, a world-renowned independent research and treatment center for...

A COVID-19 investigational vaccine developed by City of Hope scientists and now licensed to GeoVax Labs Inc. produced a robust neutralizing antibody and T cell (an immune cell) response against...

CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   •    The vaccine strategy used to generate this candidate has a record of safety and efficacy, rapid immune response and lasting protection   •  ...

Cancer care is changing rapidly, and the pace of change is accelerating. In 2019, major advances in precision medicine, gene-based therapy, immunotherapy and many other areas brought new hope to...

John Zaia, M.D. The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hope’s John Zaia, M.D., for a clinical study on the use of blood plasma as a...

City of Hope’s position as a leader in research and bioscience was once again evident at the recent Los Angeles Bioscience Ecosystem Summit (LABEST), the premier showcase for bioscience innovation...